摘要:
A one-step method (and sphering agent/fixing agent useful therein) for treating mammalian red blood cells in a sample which can be effectively measured electrooptically for determination of red blood cell volumes, which comprises treating an anticoagulated whole blood sample with a single aqueous sphering agent/fixing agent reagent at a temperature in the range of 4°C to 37°C over a reaction period of up to 180 seconds employing a whole blood dilution factor of from 1:300 to 1:4,000 wherein said ona step, single reagent treatment provides isovoluments sphering of the erythrocytes in the semple independent of the concentration of said erythrocytes in the whole Diood sample and without inducing lysis of said erychwocytes in the resulting diluted semple. The preferred sptering agent is an alkali metal salt of an alkyl sulfate irr an amount 0.5 to 3.0 mg %, and the preferred fixing agent is an aldehyde in an amount from 0.05 to 0.3%.
摘要:
A flow cytometry method reproducibly detects and counts a lymphocyte population of interest in a leukocyte suspension or whole blood sample in which the red cells are subsequently lysed. The suspension (or sample) is combined with a reagent comprising a primary antibody, either native, carrying an attached enzyme or biotin or other label, and a fixative reagent, in either order. Where the enzyme is not attached, an enzyme is coupled specifically to the primary antibody. The fixed suspension is reacted with a color- producing enzyme-cytochemical reagent. The suspension, now including stained and unstained fixed cells, is passed through a flow cytometer and the cells are characterized and counted on the basis of their light-scattering and light-absorbing properties.
摘要:
Whole blood is treated to sphere, and optionally also fix, red blood cells in order to be able better to determine their volume and (optionally) number, by treating the blood with (a) an isotonic solution of a sphering agent, and (b) an isotonic solution of a sphering agent and a protein, to provide a weight ratio of protein to sphering agent of from 20:1 to 70:1, and a final concentration of sphering agent of from 2 to 10 mg/100 ml. In a modification of this procedure, use is made of the protein endogenous to the blood and step (b) is replaced by (c) treating the mixture from step (a) with an isotomic solution of a fixing agent such as glutaraldehyde. Reagent compositions comprising a sphering agent and a protein, for use in the above method, are also described.